Dialysis Central Catheters, Arterial Shunts To Be Compared In CDC Study
This article was originally published in The Gray Sheet
A Centers for Disease Control and Prevention study comparing the rates of bloodstream and vascular access infections in dialysis patients with arterial venous shunts to those with central venous catheters is expected to begin before Oct. 1, CDC says.
You may also be interested in...
A Phase III trial testing the antibody-drug conjugate sacituzumab govitecan was stopped early for efficacy, boding well for the BLA pending at the US FDA.
Deal Snapshot: Six companies seek to collect convalescent plasma from COVID-19 survivors to quickly develop hyperimmune immunoglobulin therapy for serious complications of the virus.
Pharmaceutical companies struggling to keep up with coronavirus-related supply chain havoc asked to keep the US regulator informed as situation unfolds.